title: Seroprevalence of anti-hepatitis a antibody among 1 - 15 year old children in kashan-iran.
abstract: BACKGROUND
  Worldwide, hepatitis A is a common infection during childhood especially in developing countries. It can cause severe complications in adults and patients with underlying diseases.
  
  
  OBJECTIVE
  This study was performed to determine the seroprevalence of hepatitis A in 1 - 15 year-old children of Kashan.
  
  
  METHODS
  This cross-sectional study was performed on 666 one to fifteen year-old children from health-care centers in Kashan city during 2012. Total antibodies against hepatitis A were measured in sera by enzyme-linked immunosorbent assay (ELISA).
  
  
  RESULTS
  Totally, 3.9% of children were seropositive. Mean number of family members was 3.92 ± 0.89. There was no difference in seroprevalence of hepatitis A relative to sex, family size, mean age and age groups.
  
  
  CONCLUSIONS
  In this city, a great proportion of children are susceptible to hepatitis A and it's complications at an older age. This decrease in seropositivity may be caused by elevated hygien level. According to our results hepatitis A vaccination is recommended at early childhood such as that of other regions where low prevalence of hepatitis A infection is found.
authors: Department of Pediatrics, Kashan University of Medical Sciences, Kashan, IR Iran.
authors: Abbas
authors: A
authors: Taghavi Ardakani
authors: Babak
authors: B
authors: Soltani
authors: Mojtaba
authors: M
authors: Sehat
authors: Somayeh
authors: S
authors: Namjoo
authors: Mostafa
authors: M
authors: Haji Rezaei
keywords: Antibody; Epidemiology; Hepatitis A
references: Int J Epidemiol. 2008 Aug;37(4):852-61
references: 18653514
references: Rev Inst Med Trop Sao Paulo. 1998 Mar-Apr;40(2):105-6
references: 9755564
references: Pediatrics. 1996 Dec;98(6 Pt 1):1207-15
references: 8951284
references: N Engl J Med. 1985 Oct 24;313(17):1059-67
references: 2413356
references: Eur J Epidemiol. 1997 Dec;13(8):875-8
references: 9476815
references: Science. 1973 Dec 7;182(4116):1026-8
references: 4356028
references: J Pediatr Gastroenterol Nutr. 2002 Nov;35(5):595-6
references: 12487128
references: J Viral Hepat. 2000 May;7 Suppl 1:27-8
references: 10866842
references: Hepat Mon. 2011 Apr 1;11(4):285-8
references: 22706273
references: Vaccine. 2000 Feb 18;18 Suppl 1:S61-4
references: 10683551
references: Eur J Epidemiol. 2000 Jun;16(6):507-10
references: 11049092
references: Pediatr Infect Dis J. 2005 Jun;24(6):514-9
references: 15933561
references: J Gastroenterol Hepatol. 2002 Nov;17(11):1187-91
references: 12453278
references: World J Gastroenterol. 2009 Jan 7;15(1):102-5
references: 19115474
references: Eur J Epidemiol. 2004;19(3):275-8
references: 15117123
references: Am J Trop Med Hyg. 1999 Nov;61(5):825-9
references: 10586919
references: Nursing. 2004 Jun;34(6):45-7
references: 15209070
references: Trop Gastroenterol. 2008 Jul-Sep;29(3):160-2
references: 19115608
references: Vaccine. 1997 Apr-May;15(6-7):612-5
references: 9178459
references: J Infect Dis. 1989 Nov;160(5):887-90
references: 2572653
references: Infect Dis Clin North Am. 2000 Sep;14(3):605-15
references: 10987112
references: Vaccine. 2002 Mar 15;20(13-14):1699-701
references: 11906754
references: MMWR Recomm Rep. 2006 May 19;55(RR-7):1-23
references: 16708058
references: Arch Pediatr Adolesc Med. 1996 Jul;150(7):733-9
references: 8673200
references: JAMA. 2001 Dec 19;286(23):2968-73
references: 11743837
references: J Viral Hepat. 2002 Mar;9(2):101-6
references: 11876791
references: J Med Virol. 2001 Jun;64(2):104-8
references: 11360241
references: N Engl J Med. 1998 Jan 29;338(5):286-90
references: 9445408
references: Pediatr Infect Dis J. 2004 Jun;23(6):551-2
references: 15194837